BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
32990384
Number of visits today
4739
Number of downloads
16170351
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Samanta D. A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development. Epilepsy Behav 2022;128:108577. [PMID: 35151190 DOI: 10.1016/j.yebeh.2022.108577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Reddy DS. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies. Exp Neurol 2023;359:114237. [PMID: 36206806 DOI: 10.1016/j.expneurol.2022.114237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Elkommos S, Mula M. Current and future pharmacotherapy options for drug-resistant epilepsy. Expert Opin Pharmacother 2022. [PMID: 36154780 DOI: 10.1080/14656566.2022.2128670] [Reference Citation Analysis]
3 Samanta D. Pharmacotherapeutic management of seizures in patients with Angleman syndrome. Expert Opin Pharmacother 2022. [PMID: 35862628 DOI: 10.1080/14656566.2022.2105141] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345